COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Nov 10, 2020
Trial Information
Current as of August 02, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "ACCURATE-BL-COVID-19" is focused on improving the way we test for COVID-19. Researchers in Baselland, Switzerland, are working to develop a reliable and simple testing method that can use saliva samples to detect the virus. This study aims to help with contact tracing, which is important for controlling the spread of COVID-19. They will be testing different techniques, including advanced methods that can quickly identify the virus in patients.
To participate in this trial, individuals must be symptomatic patients who are getting tested for COVID-19. Unfortunately, adults who are not able to make decisions about their health care will not be eligible to join. If you qualify and choose to participate, you can expect to provide saliva samples that will be analyzed to help improve testing methods for the virus. This research is crucial for enhancing our ability to detect and monitor COVID-19 in the community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • symptomatic patients getting tested for COVID-19
- Exclusion Criteria:
- • mentally incompetent adults
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liestal, , Switzerland
Patients applied
Trial Officials
Miodrag Savic, Dr. med. Dr. med. dent.
Principal Investigator
Cantonal Office of Public Health, Economics and Health Directorate, Canton Basel-Landschaft
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials